Published in Immunology on January 01, 2015
Mechanistic Analysis of the Effect of Deamidation on the Immunogenicity of Anthrax Protective Antigen. Clin Vaccine Immunol (2016) 0.75
An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. Nature (1998) 2.44
PEAKS DB: de novo sequencing assisted database search for sensitive and accurate peptide identification. Mol Cell Proteomics (2011) 2.37
Programming dendritic cells to induce T(H)2 and tolerogenic responses. Nat Immunol (2010) 2.29
Lysosomal cysteine proteases regulate antigen presentation. Nat Rev Immunol (2003) 2.25
Microcolumns with self-assembled particle frits for proteomics. J Chromatogr A (2002) 2.17
Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. Nat Rev Immunol (2009) 2.11
Class II MHC peptide loading by the professionals. Curr Opin Immunol (2004) 1.51
Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo. J Exp Med (2000) 1.45
CD1c tetramers detect ex vivo T cell responses to processed phosphomycoketide antigens. J Exp Med (2013) 1.16
Immunostimulatory activity of haptenated proteins. Proc Natl Acad Sci U S A (2009) 1.10
Immunomodulatory dendritic cells inhibit Th1 responses and arthritis via different mechanisms. J Immunol (2007) 1.09
Immunization with glycosylated Kb-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells. Eur J Immunol (1996) 1.08
Cathepsin S and an asparagine-specific endoprotease dominate the proteolytic processing of human myelin basic protein in vitro. Eur J Immunol (2001) 1.07
Autoantigenesis: the evolution of protein modifications in autoimmune disease. Curr Opin Immunol (2011) 1.03
T cell receptor (TCR) interaction with haptens: metal ions as non-classical haptens. Toxicology (2005) 0.99
Granzyme B proteolysis of a neuronal glutamate receptor generates an autoantigen and is modulated by glycosylation. J Immunol (2001) 0.99
T cell immune responses to haptens. Structural models for allergic and autoimmune reactions. Toxicology (1996) 0.97
Synthetic peptides anchor T cell-specific TNP epitopes to MHC antigens. J Immunol (1992) 0.95
Microbe-dendritic cell dialog controls regulatory T-cell fate. Immunol Rev (2010) 0.92
A chemically inert drug can stimulate T cells in vitro by their T cell receptor in non-sensitised individuals. Toxicology (2004) 0.86
The impact of PEGylation on protein immunogenicity. Int Immunopharmacol (2013) 0.83
T cells specific to hapten carrier but not to carrier alone assist in the production of anti-hapten and anti-carrier antibodies. Int Immunol (2007) 0.80
Coated cross-species antibodies by mannosamine-biotin adduct confer protection against snake venom without eliciting humoral immune response. Vaccine (2010) 0.79
Transcutaneous immunization with hydrophilic recombinant gp100 protein induces antigen-specific cellular immune response. Cell Immunol (2010) 0.78
Structure-immune response relationships of hapten-modified collagen II peptides in a T-cell model of allergic contact dermatitis. Chem Res Toxicol (2008) 0.78
Mannosamine-biotin as a novel masking agent for coating IgG for immune response silencing and augmentation of antibody-antigen interaction. Vaccine (2009) 0.78
Improving large-scale proteomics by clustering of mass spectrometry data. Proteomics (2004) 2.44
Glabrene and isoliquiritigenin as tyrosinase inhibitors from licorice roots. J Agric Food Chem (2003) 2.28
Chalcones as potent tyrosinase inhibitors: the effect of hydroxyl positions and numbers. Phytochemistry (2004) 1.89
The HLA-B*2705 peptidome. Arthritis Rheum (2010) 1.76
Chalcones as potent tyrosinase inhibitors: the importance of a 2,4-substituted resorcinol moiety. Bioorg Med Chem (2005) 1.43
The turnover kinetics of major histocompatibility complex peptides of human cancer cells. Mol Cell Proteomics (2005) 1.33
The E2 ubiquitin-conjugating enzymes direct polyubiquitination to preferred lysines. J Biol Chem (2010) 1.28
The ubiquitin E3 ligase MARCH7 is differentially regulated by the deubiquitylating enzymes USP7 and USP9X. Traffic (2008) 1.22
Stable isotope labeling by amino acids in cell culture and differential plasma membrane proteome quantitation identify new substrates for the MARCH9 transmembrane E3 ligase. Mol Cell Proteomics (2009) 1.19
Soluble plasma HLA peptidome as a potential source for cancer biomarkers. Proc Natl Acad Sci U S A (2010) 1.18
Molecular phenotype of zebrafish ovarian follicle by serial analysis of gene expression and proteomic profiling, and comparison with the transcriptomes of other animals. BMC Genomics (2006) 1.11
Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine. Atherosclerosis (2004) 1.03
Inhibition of serotonin re-uptake by licorice constituents. J Mol Neurosci (2003) 1.00
Estrogen-like activity of licorice root constituents: glabridin and glabrene, in vascular tissues in vitro and in vivo. J Steroid Biochem Mol Biol (2004) 0.98
Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype. Atherosclerosis (2011) 0.97
Capture of tumor cell membranes by trogocytosis facilitates detection and isolation of tumor-specific functional CTLs. Cancer Res (2008) 0.97
Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor-specific antigens. Eur J Immunol (2002) 0.94
The direction of protein entry into the proteasome determines the variety of products and depends on the force needed to unfold its two termini. Mol Cell (2012) 0.94
Oxysterol as a marker of atherogenic dyslipidemia in adolescence. J Clin Endocrinol Metab (2008) 0.92
The nature and extent of contributions by defective ribosome products to the HLA peptidome. Proc Natl Acad Sci U S A (2014) 0.92
Tumor antigens and proteomics from the point of view of the major histocompatibility complex peptides. Mol Cell Proteomics (2003) 0.91
Comparative proteomics of the developing fish (zebrafish and gilthead seabream) oocytes. Comp Biochem Physiol Part D Genomics Proteomics (2007) 0.90
The effect of proteasome inhibition on the generation of the human leukocyte antigen (HLA) peptidome. Mol Cell Proteomics (2013) 0.89
Enhanced substituted resorcinol hydrophobicity augments tyrosinase inhibition potency. J Med Chem (2007) 0.89
Multiple, non-conserved, internal viral ligands naturally presented by HLA-B27 in human respiratory syncytial virus-infected cells. Mol Cell Proteomics (2010) 0.88
Evaluation of prefractionation methods as a preparatory step for multidimensional based chromatography of serum proteins. Proteomics (2005) 0.88
Estrogenic activity of glabridin and glabrene from licorice roots on human osteoblasts and prepubertal rat skeletal tissues. J Steroid Biochem Mol Biol (2004) 0.87
Recombinant hydrophilic human gp100: uptake by dendritic cells and stimulation of autologous CD8+ lymphocytes from melanoma patients. Immunol Lett (2004) 0.87
Monoubiquitinylation regulates endosomal localization of Lst2, a negative regulator of EGF receptor signaling. Dev Cell (2009) 0.86
The effect of oxidative stress on ERalpha and ERbeta expression. J Steroid Biochem Mol Biol (2002) 0.86
Insight into molecular pathways of retinal metabolism, associated with vitellogenesis in zebrafish. Am J Physiol Endocrinol Metab (2011) 0.85
Brain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase-1. J Neurochem (2009) 0.85
Large-scale analysis of HLA peptides presented by HLA-Cw4. Immunogenetics (2003) 0.84
The origin of proteasome-inhibitor resistant HLA class I peptidomes: a study with HLA-A*68:01. Mol Cell Proteomics (2011) 0.84
Effects of heme oxygenase-1 expression on sterol homeostasis in rat astroglia. Free Radic Biol Med (2006) 0.84
Paraoxonase 1 activities, regulation, and interactions with atherosclerotic lesion. Curr Opin Lipidol (2013) 0.84
Novel technologies for cancer biomarker discovery: humoral proteomics. Cancer Biomark (2007) 0.83
Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cells. J Virol (2011) 0.83
The impact of PEGylation on protein immunogenicity. Int Immunopharmacol (2013) 0.83
Human atherosclerotic plaque lipid extract promotes expression of proinflammatory factors in human monocytes and macrophage-like cells. Atherosclerosis (2011) 0.82
Natural HLA-B*2705 protein ligands with glutamine as anchor motif: implications for HLA-B27 association with spondyloarthropathy. J Biol Chem (2013) 0.82
Impact of heme oxygenase-1 on cholesterol synthesis, cholesterol efflux and oxysterol formation in cultured astroglia. J Neurochem (2008) 0.82
The effects and mechanism of flavonoid-rePON1 interactions. Structure-activity relationship study. Bioorg Med Chem (2013) 0.81
Characterization of the PON1 active site using modeling simulation, in relation to PON1 lactonase activity. Bioorg Med Chem (2008) 0.81
Diversity of natural self-derived ligands presented by different HLA class I molecules in transporter antigen processing-deficient cells. PLoS One (2013) 0.80
A melanoma multiepitope polypeptide induces specific CD8+ T-cell response. Cell Immunol (2008) 0.80
Human carotid lesion linoleic acid hydroperoxide inhibits paraoxonase 1 (PON1) activity via reaction with PON1 free sulfhydryl cysteine 284. Free Radic Biol Med (2010) 0.80
Immunological activation following transcutaneous delivery of HR-gp100 protein. Vaccine (2007) 0.80
Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway. Neuropharmacology (2012) 0.79
Genetic and antigenic characterization of sigma C protein from avian reovirus. Avian Pathol (2010) 0.79
Nanofibers made of globular proteins. Biomacromolecules (2008) 0.79
Glabridin protects paraoxonase 1 from linoleic acid hydroperoxide inhibition via specific interaction: a fluorescence-quenching study. J Agric Food Chem (2012) 0.79
Characterization of oxidative stress in blood from diabetic vs. hypercholesterolaemic patients, using a novel synthesized marker. Biomarkers (2008) 0.79
Coated cross-species antibodies by mannosamine-biotin adduct confer protection against snake venom without eliciting humoral immune response. Vaccine (2010) 0.79
Novel HLA-B27-restricted epitopes from Chlamydia trachomatis generated upon endogenous processing of bacterial proteins suggest a role of molecular mimicry in reactive arthritis. J Biol Chem (2013) 0.79
Potential skin antiinflammatory effects of 4-methylthiobutylisothiocyanate (MTBI) isolated from rocket (Eruca sativa) seeds. Biofactors (2009) 0.79
Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects. Free Radic Biol Med (2008) 0.79
TAP-independent human histocompatibility complex-Cw1 antigen processing of an HIV envelope protein conserved peptide. AIDS (2011) 0.79
Comparative proteomics of small cell lung carcinoma. Cancer Biomark (2006) 0.78
Increased Levels of Human Carotid Lesion Linoleic Acid Hydroperoxide in Symptomatic and Asymptomatic Patients Is Inversely Correlated with Serum HDL and Paraoxonase 1 Activity. J Lipids (2012) 0.78
Mannosamine-biotin as a novel masking agent for coating IgG for immune response silencing and augmentation of antibody-antigen interaction. Vaccine (2009) 0.78
Paraoxonase1 deficiency in mice is associated with hypotension and increased levels of 5,6-epoxyeicosatrienoic acid. Atherosclerosis (2012) 0.78
Transcutaneous immunization with hydrophilic recombinant gp100 protein induces antigen-specific cellular immune response. Cell Immunol (2010) 0.78
Immune responses to mucosal vaccination by the recombinant A1 and N proteins of infectious bronchitis virus. Viral Immunol (2012) 0.78
Paraoxonase 1 protects macrophages from atherogenicity of a specific triglyceride isolated from human carotid lesion. Free Radic Biol Med (2011) 0.78